Wed, Jul 23, 2014, 5:28 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Exelixis, Inc. Message Board

  • wilderguide wilderguide Apr 2, 2013 2:18 PM Flag

    NCI dosing study: Advanced solid tumors in HIV

    "Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors With Human Immunodeficiency Virus" currently #18 of 39 trials at clinicaltrialsdotcom. Posted 4/1/13.

    I'm not sure which is the more bullish indication...the ongoing clinical mojo...
    ...or the Message Board lunacy that seems to accompany the clinical momentum.
    At times it almost seems like a race.

3.78+0.19(+5.29%)Jul 23 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.